Google AI
The Times Australia
The Times World News

.

A major ivermectin study has been withdrawn, so what now for the controversial drug?

  • Written by: Andrew McLachlan, Head of School and Dean of Pharmacy, University of Sydney
A major ivermectin study has been withdrawn, so what now for the controversial drug?from www.shutterstock.com

Ivermectin, an existing drug against parasites including head lice, has had a chequered history when it comes to treating COVID-19.

The bulk of studies so far show there’s not enough evidence ivermectin is useful in treating or preventing COVID-19, either alone or with antibiotics or supplements.

Yet interest in the...

Read more: A major ivermectin study has been withdrawn, so what now for the controversial drug?

Times Magazine

What next from Apple

The question of what comes next for Apple Inc. is no longer theoretical. With leadership transitio...

Leapmotor Hybrid EV Review

The Leapmotor hybrid EV—most notably the Leapmotor C10 REEV (range-extended electric vehicle)—has ...

Navman Gets Even Smarter with 2026 MiVue™ Dash Cams

Introducing NEW Integrated Smart Parking and Australia-First Extended Recording Mode Navman to...

Why Interactive Panels Are Replacing Traditional Whiteboards in Perth

Whiteboards have been part of classrooms and meeting rooms for decades. They’re familiar, flexible...

The Engineering Innovations Transforming the Australian Heavy Transport Fleet

Australia is a massive continent, and its national supply chain relies almost entirely on the road...

Petrol Prices Soar and Rationing Fears Grow — The 10 Cheapest Cars to Run in Australia

Australians are once again confronting a familiar pressure point: the cost of fuel. With petrol pr...

Technology

What next from Apple

The question of what comes next for Apple Inc. is no longer theoretical. With leadership transitio...

Local News

Court outcome reinforces wildlife traffick…

A 20-year-old man has been fined close to $50,000 and ordered to pay costs after pleading guilty t...

Culture

GINA WILLIAMS & GUY GHOUSE LIVE AT THE EL…

After 15 years of performing around the world, recording studio albums and unveiling two opera works...

Travel

Club Med Expands Exclusive Collection Portfol…

Club Med, the global leader in premium all-inclusive holidays for 75 years, and Central Group Capita...

The Times Features

GINA WILLIAMS & GUY GHOUSE LIVE AT THE ELLINGTON’ D…

After 15 years of performing around the world, recording studio albums and unveiling two opera works...

The Quiet Luxury of Ink: Rediscovering the Joy of Writi…

In an age dominated by screens, taps and instant communication, the simple act of writing by hand ...

Owning a Restaurant: Buying One or Braving the Challeng…

Owning a restaurant has long been one of the most alluring—and misunderstood—paths in small busine...

Supermarket Prices Are Up — and So Is Dinner at a Modes…

For many Australians, the weekly grocery shop and a simple night out for dinner have quietly becom...

In 2006, The Devil Wears Prada Became One of the First …

When The Devil Wears Prada premiered in 2006, it was marketed as a sharp, entertaining adaptation ...

Protecting High-Value Homes Before Sale: A Practical Gu…

Selling a premium home is rarely just about listing and waiting. At the top end of the market, buy...

Eumundi Markets: One of the Sunshine Coast’s most power…

As Queensland prepares for Small Business Month in May, Experience Eumundi is highlighting the cri...

Club Med Expands Exclusive Collection Portfolio with a …

Club Med, the global leader in premium all-inclusive holidays for 75 years, and Central Group Capita...

Cost of living increases worry Farrer residents

COST OF LIVING ‘CRUNCH’ HITS FARRER HARD, THE NATIONALS HEAR During a visit to Albury this week...